200 related articles for article (PubMed ID: 28456624)
1. Fusion proteins of flagellin and the major birch pollen allergen Bet v 1 show enhanced immunogenicity, reduced allergenicity, and intrinsic adjuvanticity.
Kitzmüller C; Kalser J; Mutschlechner S; Hauser M; Zlabinger GJ; Ferreira F; Bohle B
J Allergy Clin Immunol; 2018 Jan; 141(1):293-299.e6. PubMed ID: 28456624
[TBL] [Abstract][Full Text] [Related]
2. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
[TBL] [Abstract][Full Text] [Related]
3. Conjugation of wildtype and hypoallergenic mugwort allergen Art v 1 to flagellin induces IL-10-DC and suppresses allergen-specific TH2-responses in vivo.
Schülke S; Kuttich K; Wolfheimer S; Duschek N; Wangorsch A; Reuter A; Briza P; Pablos I; Gadermaier G; Ferreira F; Vieths S; Toda M; Scheurer S
Sci Rep; 2017 Sep; 7(1):11782. PubMed ID: 28924222
[TBL] [Abstract][Full Text] [Related]
4. Critical role of mammalian target of rapamycin for IL-10 dendritic cell induction by a flagellin A conjugate in preventing allergic sensitization.
Schülke S; Fiedler AH; Junker AC; Flaczyk A; Wolfheimer S; Wangorsch A; Heinz A; Beckert H; Nagl B; Bohle B; Vieths S; Toda M; Scheurer S
J Allergy Clin Immunol; 2018 May; 141(5):1786-1798.e11. PubMed ID: 28886863
[TBL] [Abstract][Full Text] [Related]
5. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
6. The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals.
Smole U; Radauer C; Lengger N; Svoboda M; Rigby N; Bublin M; Gaier S; Hoffmann-Sommergruber K; Jensen-Jarolim E; Mechtcheriakova D; Breiteneder H
PLoS One; 2015; 10(1):e0117904. PubMed ID: 25635684
[TBL] [Abstract][Full Text] [Related]
7. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.
Ferreira F; Hirtenlehner K; Jilek A; Godnik-Cvar J; Breiteneder H; Grimm R; Hoffmann-Sommergruber K; Scheiner O; Kraft D; Breitenbach M; Rheinberger HJ; Ebner C
J Exp Med; 1996 Feb; 183(2):599-609. PubMed ID: 8627171
[TBL] [Abstract][Full Text] [Related]
8. NFκB- and MAP-Kinase Signaling Contribute to the Activation of Murine Myeloid Dendritic Cells by a Flagellin A:Allergen Fusion Protein.
Moeller T; Wolfheimer S; Goretzki A; Scheurer S; Schülke S
Cells; 2019 Apr; 8(4):. PubMed ID: 30991709
[TBL] [Abstract][Full Text] [Related]
9. A novel approach to specific allergy treatment: the recombinant allergen-S-layer fusion protein rSbsC-Bet v 1 matures dendritic cells that prime Th0/Th1 and IL-10-producing regulatory T cells.
Gerstmayr M; Ilk N; Schabussova I; Jahn-Schmid B; Egelseer EM; Sleytr UB; Ebner C; Bohle B
J Immunol; 2007 Dec; 179(11):7270-5. PubMed ID: 18025169
[TBL] [Abstract][Full Text] [Related]
10. Human blood basophils do not act as antigen-presenting cells for the major birch pollen allergen Bet v 1.
Kitzmüller C; Nagl B; Deifl S; Walterskirchen C; Jahn-Schmid B; Zlabinger GJ; Bohle B
Allergy; 2012 May; 67(5):593-600. PubMed ID: 22188598
[TBL] [Abstract][Full Text] [Related]
11. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1.
Gieras A; Cejka P; Blatt K; Focke-Tejkl M; Linhart B; Flicker S; Stoecklinger A; Marth K; Drescher A; Thalhamer J; Valent P; Majdic O; Valenta R
J Immunol; 2011 May; 186(9):5333-44. PubMed ID: 21451110
[TBL] [Abstract][Full Text] [Related]
12. A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity.
Bohle B; Breitwieser A; Zwölfer B; Jahn-Schmid B; Sára M; Sleytr UB; Ebner C
J Immunol; 2004 Jun; 172(11):6642-8. PubMed ID: 15153479
[TBL] [Abstract][Full Text] [Related]
13. A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy.
Schülke S; Burggraf M; Waibler Z; Wangorsch A; Wolfheimer S; Kalinke U; Vieths S; Toda M; Scheurer S
J Allergy Clin Immunol; 2011 Dec; 128(6):1340-1348.e12. PubMed ID: 21872305
[TBL] [Abstract][Full Text] [Related]
14. A hypoallergenic variant of the major birch pollen allergen shows distinct characteristics in antigen processing and T-cell activation.
Kitzmüller C; Wallner M; Deifl S; Mutschlechner S; Walterskirchen C; Zlabinger GJ; Ferreira F; Bohle B
Allergy; 2012 Nov; 67(11):1375-82. PubMed ID: 22973879
[TBL] [Abstract][Full Text] [Related]
15. Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of naïve CD4+ T cells from allergic patients.
Deifl S; Kitzmüller C; Steinberger P; Himly M; Jahn-Schmid B; Fischer GF; Zlabinger GJ; Bohle B
Allergy; 2014 Dec; 69(12):1602-9. PubMed ID: 25093709
[TBL] [Abstract][Full Text] [Related]
16. Recombinant PreS-fusion protein vaccine for birch pollen and apple allergy.
Khaitov M; Shilovskiy I; Valenta R; Weber M; Korneev A; Tulaeva I; Gattinger P; van Hage M; Hofer G; Konradsen JR; Keller W; Akinfenwa O; Poroshina A; Ilina N; Fedenko E; Elisyutina O; Litovkina A; Smolnikov E; Nikonova A; Rybalkin S; Aldobaev V; Smirnov V; Shershakova N; Petukhova O; Kudlay D; Shatilov A; Timofeeva A; Campana R; Udin S; Skvortsova V
Allergy; 2024 Apr; 79(4):1001-1017. PubMed ID: 37855043
[TBL] [Abstract][Full Text] [Related]
17. Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001.
Smole U; Balazs N; Hoffmann-Sommergruber K; Radauer C; Hafner C; Wallner M; Ferreira F; Grössinger R; de Jong EC; Wagner S; Breiteneder H
Immunobiology; 2010 Nov; 215(11):903-9. PubMed ID: 20005001
[TBL] [Abstract][Full Text] [Related]
18. Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1.
Akinfenwa O; Huang HJ; Linhart B; Focke-Tejkl M; Vrtala S; Poroshina A; Nikonova A; Khaitov M; Campion NJ; Eckl-Dorna J; Niederberger-Leppin V; Kratzer B; Tauber PA; Pickl WF; Kundi M; Campana R; Valenta R
Front Immunol; 2021; 12():744544. PubMed ID: 34795666
[TBL] [Abstract][Full Text] [Related]
19. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
[TBL] [Abstract][Full Text] [Related]
20. Epicutaneous immune modulation with Bet v 1 plus R848 suppresses allergic asthma in a murine model.
Siebeneicher S; Reuter S; Krause M; Wangorsch A; Maxeiner J; Wolfheimer S; Schülke S; Naito S; Heinz A; Taube C; Vieths S; Scheurer S; Toda M
Allergy; 2014 Mar; 69(3):328-37. PubMed ID: 24329861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
